Home > Healthcare > Pharmaceuticals > Active Pharmaceutical Ingredients > Montelukast Sodium Market

Montelukast Sodium Market Share

Report ID: GMI9309
Published Date: Apr 2024
Report Format: PDF

Download Free Sample

Montelukast Sodium Market Share

The montelukast sodium industry is competitive in nature, with several large multinationals and small and mid-sized companies competing in the industry. The development and launch of novel advanced products and services based on different technologies is among a key market strategy. Some of the leading industry players have a notable presence in the market.

Montelukast Sodium Market Companies

Some of the eminent market participants operating in the montelukast sodium industry include:

Apotex Inc.
Cipla Limited
Dr. Reddy’s Laboratories Ltd.
Intas Pharmaceuticals Ltd
Merck & Co., Inc.
Morepen Laboratories Limited
Mylan N.V.
Sandoz AG
Sanofi
Sun Pharma Industries Limited.
Teva Pharmaceutical Industries Limited

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

Montelukast sodium market size was USD 670.7 million in 2023 and is expected to register 11.4% CAGR from 2024-2032 owing to the increasing prevalence of respiratory diseases includes asthma, allergic rhinitis worldwide.

Montelukast sodium industry from the montelukast sodium amorphous segment reached USD 387.6 million in 2023 and is expected to register an appreciable CAGR from 2024-2032 due to having a higher solubility than their crystalline counterparts.

U.S. montelukast sodium industry is expected to register 11.1% CAGR from 2024-2032 due to the presence of highly developed healthcare infrastructure with advanced medical facilities and a robust pharmaceutical industry in the region.

Dr. Reddy’s Laboratories Ltd., Intas Pharmaceuticals Ltd, Merck & Co., Inc., Morepen Laboratories Limited, Mylan N.V., Sandoz AG, Sanofi, Sun Pharma Industries Limited., and Teva Pharmaceutical Industries Limited, are some of the major montelukast sodium companies worldwide.